USC.edu
Are You a Patient?

Yan Ning

Clinical Research Data Specialist Lead

Image of Yan Ning
Is this your profile? Click to edit
Phone +1 323 409 4365
Email [email protected]
CTSI Profile

Publications

  • Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients. Pharmacogenet Genomics. 2014 Dec; 24(12):588-96.. View in PubMed
  • Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. Pharmacogenet Genomics. 2014 Nov; 24(11):539-47.. View in PubMed
  • Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Mol Cancer Ther. 2014 Feb; 13(2):528-39.. View in PubMed
  • Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Mol Cancer Ther. 2013 Oct; 12(10):2261-72.. View in PubMed
  • Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol. 2012 Jun 20; 30(18):2265-72.. View in PubMed
  • Targeting IL-8 in colorectal cancer. Expert Opin Ther Targets. 2012 May; 16(5):491-7.. View in PubMed
  • The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012 Jun; 11(6):1353-64.. View in PubMed
  • Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res. 2012 Feb 01; 18(3):645-53.. View in PubMed
  • Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res. 2011 Nov 01; 17(21):6934-43.. View in PubMed
  • Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2011 Sep 01; 17(17):5783-92.. View in PubMed

Similar People